[go: up one dir, main page]

FR2750605B1 - PHARMACEUTICAL COMPOSITION WITH ANTI-ALCOHOLIC AND NOOTROPIC EFFECTS - Google Patents

PHARMACEUTICAL COMPOSITION WITH ANTI-ALCOHOLIC AND NOOTROPIC EFFECTS

Info

Publication number
FR2750605B1
FR2750605B1 FR9608205A FR9608205A FR2750605B1 FR 2750605 B1 FR2750605 B1 FR 2750605B1 FR 9608205 A FR9608205 A FR 9608205A FR 9608205 A FR9608205 A FR 9608205A FR 2750605 B1 FR2750605 B1 FR 2750605B1
Authority
FR
France
Prior art keywords
alcoholic
pharmaceutical composition
nootropic effects
nootropic
effects
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9608205A
Other languages
French (fr)
Other versions
FR2750605A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from RU9595100307A external-priority patent/RU2097034C1/en
Priority to RU9595100307A priority Critical patent/RU2097034C1/en
Priority to JP8521587A priority patent/JPH09510738A/en
Priority to PCT/RU1996/000006 priority patent/WO1996021446A1/en
Priority to DE19626431A priority patent/DE19626431B4/en
Priority to FR9608205A priority patent/FR2750605B1/en
Application filed by Individual filed Critical Individual
Priority to CH01664/96A priority patent/CH691791A8/en
Publication of FR2750605A1 publication Critical patent/FR2750605A1/en
Publication of FR2750605B1 publication Critical patent/FR2750605B1/en
Application granted granted Critical
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
FR9608205A 1995-01-13 1996-07-02 PHARMACEUTICAL COMPOSITION WITH ANTI-ALCOHOLIC AND NOOTROPIC EFFECTS Expired - Lifetime FR2750605B1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
RU9595100307A RU2097034C1 (en) 1995-01-13 1995-01-13 Pharmaceutical preparation showing antialcoholic and nootropic effects
JP8521587A JPH09510738A (en) 1995-01-13 1996-01-04 Pharmaceutical composition with abstinence and nuotropic effect
PCT/RU1996/000006 WO1996021446A1 (en) 1995-01-13 1996-01-04 Pharmaceutical composition with anti-alcoholic and nootropic properties
DE19626431A DE19626431B4 (en) 1995-01-13 1996-07-01 Use of a pharmaceutical composition with anti-alcoholic and nootropic effect
FR9608205A FR2750605B1 (en) 1995-01-13 1996-07-02 PHARMACEUTICAL COMPOSITION WITH ANTI-ALCOHOLIC AND NOOTROPIC EFFECTS
CH01664/96A CH691791A8 (en) 1995-01-13 1996-07-03 PHARMACEUTICAL COMPOSITION AGAINST ALCOHOL MISUSE AND WITH NOTROPER EFFECT.

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
RU9595100307A RU2097034C1 (en) 1995-01-13 1995-01-13 Pharmaceutical preparation showing antialcoholic and nootropic effects
DE19626431A DE19626431B4 (en) 1995-01-13 1996-07-01 Use of a pharmaceutical composition with anti-alcoholic and nootropic effect
FR9608205A FR2750605B1 (en) 1995-01-13 1996-07-02 PHARMACEUTICAL COMPOSITION WITH ANTI-ALCOHOLIC AND NOOTROPIC EFFECTS
CH166499 1999-09-10

Publications (2)

Publication Number Publication Date
FR2750605A1 FR2750605A1 (en) 1998-01-09
FR2750605B1 true FR2750605B1 (en) 1998-09-25

Family

ID=27428257

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9608205A Expired - Lifetime FR2750605B1 (en) 1995-01-13 1996-07-02 PHARMACEUTICAL COMPOSITION WITH ANTI-ALCOHOLIC AND NOOTROPIC EFFECTS

Country Status (1)

Country Link
FR (1) FR2750605B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6521645B2 (en) * 2000-11-20 2003-02-18 The University Of Kansas Medical Center Methods for the treatment and prevention of urinary stone disease

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4528295A (en) * 1983-08-15 1985-07-09 Boris Tabakoff Composition and method for reducing blood acetaldehyde levels
US6294520B1 (en) * 1989-03-27 2001-09-25 Albert T. Naito Material for passage through the blood-brain barrier
WO1993002682A1 (en) * 1991-08-06 1993-02-18 Labco Pharmaceuticals, Inc. Method and compositions for reducing craving for alcohol and stimulants
FR2704394B1 (en) * 1993-04-27 1995-06-02 Boiron Absorbable nutritional supplement for the treatment of hair and nails.
LU88371A1 (en) * 1993-07-12 1994-04-01 Michel Urso Prof Medecin Et Ch Reinforced essential amino acids
RU2097034C1 (en) * 1995-01-13 1997-11-27 Ирина Алексеевна Комиссарова Pharmaceutical preparation showing antialcoholic and nootropic effects

Also Published As

Publication number Publication date
FR2750605A1 (en) 1998-01-09

Similar Documents

Publication Publication Date Title
BR1100824A (en) Pharmaceutical composition and composition
BR9607317A (en) Peptides and pharmaceutical composition
BR9607318A (en) Peptides and pharmaceutical composition
AU4380896A (en) Pharmaceutical composition containing fenofibrate and polyglycolized glycerides
FR2740686B1 (en) STABLE LYOPHILIZED PHARMACEUTICAL FORMULATION
DE69632753D1 (en) Pharmaceutical preparations containing darifenacin
DE19581884T1 (en) Nesting and sequential counter
NO20021172D0 (en) Pharmaceutical composition
FI944832A0 (en) Pharmaceutical composition
FI972865A7 (en) Hydroxymethylimidazodiazepines and their esters
BR9509688A (en) Pharmaceutical composition and composition
FI954686L (en) Prolonged-release microtablet containing beta-phenylpropiophenone derivatives
LV11727A (en) Pharmaceutical composition
FI971427L (en) Peptides and pharmaceutical compositions containing them
DE19581885T1 (en) Nesting and sequential counter
FI973280A7 (en) Pharmaceutical composition
LV10579A (en) Pharmaceutical composition
FR2750605B1 (en) PHARMACEUTICAL COMPOSITION WITH ANTI-ALCOHOLIC AND NOOTROPIC EFFECTS
BR9605777A (en) Pharmaceutical composition
FI942803A0 (en) Ipsapirone-Proprietary Medicinal Products
FI962007A7 (en) Compatible substances
BR9605131A (en) Pharmaceutical composition
BR9505130A (en) Pharmaceutical composition and composition
BR9605220A (en) Gonadotropins and pharmaceutical composition
BR1100809A (en) Pharmaceutical composition and composition

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 20